789 West Pender Street
Suite 810
Vancouver, BC V6C 1H2
Canada
800-783-6056
https://www.digicann.io
Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees:
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. Nicholas J. Kuzyk M.B.A. | CEO & Director | 205k | N/A | 1980 |
Ms. Fiona Fitzmaurice ACCA, B.A., BA, C.P.A., CGA | CFO & Director | 103.45k | N/A | 1981 |
Mr. Peter Karroll | Director of Branding & Marketing | N/A | N/A | N/A |
Dr. Zbigniew Adam Szybinski M.Sc. | Vice President of Exploration | 87.8k | N/A | N/A |
Ms. Katrin Eckmans | MD & CEO of Farmako GmbH | N/A | N/A | N/A |
Digicann Ventures Inc., together with its subsidiaries, operates in the cannabis industry. The company engages in the cultivation, manufacturing, and marketing of cannabis and related products. Its flagship property is the Propagation Services Canada located in Delta, Canada. It also distributes medical cannabis in Europe. The company was formerly known as Agra Ventures Ltd. and changed its name to Digicann Ventures Inc. in August 2023. Digicann Ventures Inc. was incorporated in 2004 and is headquartered in Vancouver, Canada.
Digicann Ventures Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.